Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIPA-like domain containing 3 (NIPAL3) is a protein-coding gene that encodes a membrane transporter predicted to enable magnesium ion transmembrane transporter activity[1][2][3][4]. NIPAL3 is part of the NIPA family, proteins known for encoding receptors or transporters implicated in neurodevelopmental processes and is expressed in various tissues including the nervous system[2]. Disruption of NIPAL3 causes neurological impairments and immune disturbances in animal models, manifesting as abnormal behavior, altered immunoglobulin levels, reduced NK cell counts, and impaired lung function[2]. The human gene lies in a genomic region associated with atopic diseases and has been linked to combined oxidative phosphorylation deficiency and immunodeficiency syndromes[1][2]. Despite its physiological importance, NIPAL3 is not currently pursued as a therapeutic drug target, nor are there any known inhibitors, modulators, or drugs in clinical use or development directed at this specific transporter[1][2].
Not established, as no drugs are documented to interact directly with this molecule[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIPA-like domain containing 3 (NIPAL3).